PUBLISHER: Zhar Research | PRODUCT CODE: 2123809
PUBLISHER: Zhar Research | PRODUCT CODE: 2123809
Biomaterials for Future Regenerative, Longevity and Bionic Medicine: Technology, Markets 2027-2047
Summary
The next twenty years may see many people born with the prospect of living healthily to 120 years. That may be largely due to future biomaterials enabling such things as custom-grown replacement organs. The 259-page, commercially-oriented report, “Biomaterials for Future Regenerative, Longevity and Bionic Medicine: Technology, Markets 2027-2047”, details your opportunities in all this. That is whether you are an added-value materials supplier, device manufacturer, integrator or medical practitioner. Primary focus is the next materials and devices for the overlapping topics of regenerative and longevity medicine and bionic man and woman. For instance, see how new biomaterials will be key to the regenerative medicine market as it rises to $400 billion.
Nature and non-medical advances present huge possibilities
Some land animals live for 300 years, inspiring us to do better, and we can also learn from how some aquatic animals live for 15,000 years and regrow most organs. Living material is used in some therapy but Engineered Living Materials ELM will now take that to a new level. One later aspect – those ELM grown organs for implanting – is predicted to rise to the $10 billion level by 2047.
Benchmarking and latest advances
Importantly, the report explains your opportunities from the flood of latest research advances through 2026 because old news is misleading in this fast-moving topic. For example, the Roman Pantheon has been in use for nearly 2000 years thanks to self-healing concrete. Now attention has turned to renovation of human body with inanimate, self-healing, polymeric biomaterials.
Exceeding human capabilities?
Both inanimate and animate new biomaterials will even give us the option of superpowers beyond those of a regular human being. We already see a hint of this in dental implants incapable of toothache: shall we implant superhuman hearing or sight? Humans clip on a self-powered industrial exoskeleton to cope with heavy work so is it time for super-prosthetics as a custom-option? This report analyses these and many other options with future biomaterials.
Future biomaterials
For the purposes of this report, a biomaterial is any natural or synthetic substance engineered to interact safely with biological systems for a medical purpose, either therapeutic (treating, repairing, or replacing tissue) or diagnostic. A biomaterial (hardware oriented) is not a pharmaceutical (dose oriented), but it may be implanted or applied to deliver a pharmaceutical in a targetted and controlled manner.
Comprehensive, balanced report with much 2026 research
The Executive Summary and Conclusions (56 pages) is sufficient in itself, with the basics, six new pie charts (including materials favoured), ten of the SWOT appraisals, 12 key conclusions, roadmaps, and all 13 forecasts with tables, graphs, explanations.
Chapter 2. Learning from Nature – Self-healing, Regeneration and Longevity (13 pages) shows how understanding and copying other living things promises enormous advances in regeneration and longevity, including regrowing more parts of the body, copying mechanisms in some animals.
Chapter 3. Regenerative Medicine, Longevity, Bionic Man and Woman (15 pages) clarifies definitions, objectives, technologies, ethical and regulatory issues, including explanation of the many advances in 2025-6.
Learn the emerging materials, devices, applications
Chapter 4. Future Biomaterials Supporting Better and Longer Life: General Situation (41 pages) explains latest 2025-6 research and industry approaches and challenges to explain what will be new in the 2027-2047 timeframe. One is brain-computer interfaces with the new soft iontronics with its innovative new ionogels now succeeding in many other medical advances, including where the familiar medical hydrogels are inadequate. However, there are also radically improved hydrogels discussed that will achieve success. See definitions, scope and companies involved in new biomaterials with a need for many more. Self-healing inanimate materials and Engineered Living Materials are considered to be particularly impactful additions through 2027-2047, so they have their own separate chapters that follow.
Chapter 5. Inanimate Self-healing Materials for Longevity and Regenerative Medicine (62 pages) has many SWOT reports and infograms, 34 conclusions and much analysis of the research advances 2025-6. It finds that the trends to long life, reliability, fit-and-forget and rejuvenation are creating many medical opportunities. For example, being perfected are self-healing, bio-interfaced electronics, prosthetics, soft robotics for surgery, safety footwear, embedded sensors and embedded drug delivery systems. Self-healing biobased and polymer systems are a strong focus.
Chapter 6. Engineered Living Materials ELM for Regenerative and Longevity Medicine closes the report with a full 57 pages for here is the possibility of custom growth of your replacement kidney, heart, liver and so much more and much research is succeeding with many discussed specifics. They include dramatically better cancer immunotherapy, immune engineering, and tackling infectious keratitis, inflammatory bowel disease and surgical site infections far more effectively. Learn the basics, challenges and favored materials for ELM living materials and scaffolds. How do probiotics and exosomes fit in here? 2026 advances, listed conclusions, SOFT appraisals, benchmarking and infograms make it all clear.
The report, “Biomaterials for Future Regenerative, Longevity and Bionic Medicine: Technology, Markets 2027-2047” is your essential guide to creating a one-billion-dollar business in this rapidly emerging market.
Table of Contents
1. Executive Summary and Conclusions
- 1.1 Purpose, methodology and background of this report
- 1.2 Regenerative medicine, longevity, bionic man and woman explained
- 1.3 Twelve key conclusions
- 1.4 SWOT appraisal of regenerative medicine, longevity medicine and bionic man and woman
- 1.5 Longevity lessons from nature
- 1.6 Progress towards bionic man and woman with super-powers
- 1.7 Infograms: Examples of biomaterials, devices using them, manufacturing and handling issues
- 1.8 Importance of inanimate self-healing biomaterials and Engineered Living Materials 2027-2047
- 1.9 Ten SWOT appraisals of enabling biomaterials and technologies with materials analyses
- 1.10 Roadmaps 2027-2047
- 1.11 Market forecasts as graphs, tables, explanation 2027-2047
- 1.11.1 Regenerative medicine global market size $ billion 2027-2047
- 1.11.2 Healthcare ELM grown organ implants vs other $ billion cautious forecast 2027-2047
- 1.11.3 Healthcare ELM grown organ implants vs other $ billion topside forecast 2027-2047
- 1.11.4 Self-healing materials market for all applications: ELM vs total 2027-2047
- 1.11.5 Self-healing materials for healthcare value market: patient vs buildings and equipment $ billion 2027-2047
- 1.11.6 Percentage share of healthcare ELM value market by four regions 2027-2047
- 1.11.7 Number of healthcare ELM manufacturers 2027-2047
- 1.11.8 Maturity curves of self-healing material technologies in healthcare 2027, 2037,
2. Learning from nature – self-healing, regeneration and longevity
- 2.1 What can we learn from nature? Many species better than us, particularly aquatic
- 2.2 Other examples of superior self-healing and regrowth
- 2.3 Sometimes we know how it is done: differentiation, stem cell mediation, morphallaxis
- 2.4 Sometimes we do not know how it is done
- 2.5 Why are humans poor at regenerating? So near and yet so far
- 2.6 Longevity lessons from nature
3. Regenerative medicine, longevity, bionic man and woman
- 3.1 Regenerative medicine, longevity, bionic man and woman: infogram and SWOT
- 3.1.1 Overlapping topics
- 3.1.2 SWOT appraisal of regenerative medicine, longevity medicine and bionic man and woman
- 3.2 Regenerative medicine
- 3.2.1 Overview
- 3.2.2 Key Regenerative Medicine Technologies
- 3.2.3 Ethical and regulatory issues of regenerative medicine
- 3.2.4 Examples of advances in 2025 through
- 3.3 Longevity medicine
- 3.3.1 Overview
- 3.3.2 Longevity medicine overlaps regenerative
- 3.3.3 Ethical and regulatory issues of longevity medicine
- 3.3.4 Examples of advances 2025 through
- 3.4 Bionic man and woman
- 3.4.1 Fantasies becoming real with ethical and regulatory issues 2027-2047
- 3.4.2 Progress towards bionic man and woman with super-powers
- 3.4.3 Brain computer interfaces and other iontronics
4. Future biomaterials supporting better and longer life: general situation
- 4.1 Overview
- 4.1.1 Definitions and scope
- 4.1.2 Infogram: Examples of biomaterials, devices using them, manufacturing and handling issues
- 4.1.3 Emerging biomaterials for cancer immunotherapy and stem cell tissue engineering
- 4.1.4 Planned iontronic brain-computer interfaces, neuromorphic computing and medical sensors
- 4.1.5 Next-generation actuators for bionic man and woman
- 4.2 Increasing the functionality and effectiveness of current and future biomaterials
- 4.2.1 Emerging biomaterial types and capabilities: including gels, nanocomposites, devices
- 4.2.2 SWOT appraisal of medical ionogels, pie charts of the most successful materials in research, 2026 research advances
- 4.2.3 Advanced medical hydrogels in 2026: skin and muscle-mimicking, regenerative, other
- 4.3 Other important biomaterial advances through
- 4.4 54 of the companies involved in next-generation biomaterials
5. Inanimate self-healing materials for longevity and regenerative medicine
- 5.1 Introduction with trends, infogram and medical examples through
- 5.2 Definitions, mechanisms, emerging applications, future opportunities
- 5.3 Market drivers and options
- 5.3.1 Trend to self-healing smart biomaterials
- 5.3.2 Trend to long life, reliability, fit-and-forget, rejuvenation
- 5.3.3 Materials and manufacturer analysis: new charts
- 5.3.4 Biomimetics – much further to go
- 5.3.5 Advances in understanding natural healing leverage future self-healing materials
- 5.3.6 Beyond biomimetics
- 5.4 34 conclusions with 4 new infograms and 7 SWOT appraisals
- 5.4.1 Addressable markets: 10 general conclusions, infograms and SWOT appraisals
- 5.4.2 Emerging technologies and capabilities: 24 key conclusions, infograms, SWOT appraisals
- 5.5 Analysed examples of research on self-healing materials in 2025 through
6. Engineered Living Materials ELM for regenerative and longevity medicine
- 6.1 Introduction
- 6.2 Engineering Living Materials definition, simple subsets, SWOT appraisals
- 6.3 Biomimetic ELM design approaches
- 6.4 Four stages of ELM creation and deployment
- 6.5 Features designed into engineered living materials
- 6.6 ELM objectives and applications 2027-2047
- 6.7 ELM place in science and healthcare
- 6.8 Primary conclusions: emerging ELM markets with new infograms and pie chart analysis
- 6.9 Primary conclusions: ELM design, materials, manufacturing with new infograms, SWOT and pie chart analysis
- 6.10 Analysis of ELM benchmarking and design advances through
- 6.10.1 Benchmarking
- 6.10.2 Adaptive and evolving living materials as integrated systems
- 6.10.3 AI design created new ELM options in
- 6.10.4 Bioengineered and fungal ELM
- 6.10.5 Controlled drug delivery ELM
- 6.10.6 Living carrier matrices, living hydrogels enable self-growing and mechanically tunable ELM
- 6.10.7 Programmable materials grown directly from living cells as ELM
- 6.10.8 Tuning ELM polymer matrices to direct microbial adhesion, growth, spatial organization, phenotype
- 6.11 ELM advances for specific therapies in
- 6.11.1 Bioremediation and biotherapeutics ELM
- 6.11.2 Cancer immunotherapy ELM
- 6.11.3 Immune engineering
- 6.11.4 Infectious keratitis therapy
- 6.11.5 Inflammatory bowel disease ELM
- 6.11.6 Probiotic Living Materials ELM for vaginal imbalances and other conditions
- 6.11.7 Surgical site infections
